Latest Contracts News

Spenda Limited has accelerated its strategic turnaround by slashing operating costs by about $400,000 per month and locking in new retail contracts, while eyeing divestments and emerging tech opportunities.

Thor Energy has awarded a significant 2D seismic survey contract to Velseis for its HY-Range Project, aiming to refine exploration targets for natural hydrogen and helium in South Australia.

RemSense Technologies has raised $1.21 million through a heavily subscribed placement, targeting upgrades to its virtualplant platform and AI image analysis capabilities.

Tivan Limited has inked a Memorandum of Understanding with Aboriginal Investment NT to explore investment and Indigenous participation in the Molyhil Tungsten Project, advancing its critical minerals ambitions in the Northern Territory.

Pure Resources and Rice University have secured 'Awardable' status on the DARPA ERIS Marketplace for their advanced Carbon Nanotube Fibre 3D thermal management technology, positioning them for potential US Department of Defense contracts.

EV Resources has validated a flotation-led processing route at its Tecomatlán Plant, achieving 81.1% antimony recovery and concentrate grades up to 62.9% Sb, enabling a low-CAPEX upgrade and a compressed production timeline.

Echelon Resources has secured a three-year extension to its gas supply agreement with Genesis Energy, underpinning continued sales of Kupe gas at market-linked prices and supporting New Zealand’s domestic energy needs.

Tasmea Limited is set to acquire JPS Group for up to A$75 million, securing a foothold in Australia’s growing LNG and energy infrastructure sectors with a Tier-1 client base and a unique tech-enabled isolation technology.

Asset Vision has boosted its FY26 annual recurring revenue run rate to $6.4 million, driven by multiple new contracts across transport, social housing, and civic infrastructure sectors.

Matrix Composites & Engineering has landed a significant A$34 million subsea buoyancy contract, boosting its FY27 workload as it navigates a major acquisition proposal.

Sprintex has landed a three-year exclusive distribution agreement in Taiwan with Shing Yu, including a paid trial at TSMC’s wastewater facilities aiming to cut energy use by half.

LTR Pharma’s intranasal spray OROFLOW® has secured ethics approval for a clinical study targeting oesophageal motility disorders, marking its first foray beyond erectile dysfunction. The study, led by Dr Peter Wu, aims to validate a non-invasive alternative for swallowing difficulties in a market projected to reach US$8.1 billion by 2034.